• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植受者巨细胞病毒感染患病率及症状学的前瞻性研究。

Prospective study of the prevalence and symptomatology of cytomegalovirus infection in renal transplant recipients.

作者信息

Chatterjee S N, Jordan G W

出版信息

Transplantation. 1979 Dec;28(6):457-60.

PMID:229594
Abstract

To determine the incidence and symptomatology of cytomegalovirus (CMV) infection in renal transplant recipients, we followed 40 patients prospectively for 5 to 24 months after operation. As judged by the serological change and virus isolation from blood and/or urine, the infection rate for the entire group was 82% (33 of 40 patients). Two types of infection were recognized: primary infection that occurred in 3 patients, and reactivation infection that occurred in 30 patients. Twenty-one patients were asymptomatic and 12 were mildly symptomatic. Four had mild hepatic dysfunction; two had the CMV mononucleosis syndrome associated with mild to moderate deterioration of renal function. Two patients had hyperglycemia. One patient who reached a CMV antibody titer of 1:32,768 was totally asymptomatic other than fever of short duration. CMV-induced pneumonitis or retinitis was not noted, and there was no mortality from CMV infection in our patients. Factors which may be associated with the absence of severe manifestations of active CMV infection in these patients are discussed.

摘要

为了确定肾移植受者巨细胞病毒(CMV)感染的发生率和症状,我们对40例患者术后进行了5至24个月的前瞻性随访。根据血清学变化以及从血液和/或尿液中分离出病毒判断,整个组的感染率为82%(40例患者中的33例)。确认有两种感染类型:3例发生原发性感染,30例发生再激活感染。21例患者无症状,12例有轻微症状。4例有轻度肝功能障碍;2例患有与肾功能轻度至中度恶化相关的CMV单核细胞增多症综合征。2例患者有高血糖症。1例CMV抗体滴度达到1:32,768的患者除了有短时间发热外完全无症状。未发现CMV引起的肺炎或视网膜炎,我们的患者中也没有因CMV感染导致的死亡。本文讨论了可能与这些患者未出现活动性CMV感染严重表现相关的因素。

相似文献

1
Prospective study of the prevalence and symptomatology of cytomegalovirus infection in renal transplant recipients.肾移植受者巨细胞病毒感染患病率及症状学的前瞻性研究。
Transplantation. 1979 Dec;28(6):457-60.
2
Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.肾移植受者的巨细胞病毒病:一项关于临床特征、危险因素及对肾移植影响的前瞻性研究
Medicine (Baltimore). 1980 Jul;59(4):283-300.
3
Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.口服更昔洛韦预防肾移植术后患者巨细胞病毒感染的疗效
Clin Transplant. 1997 Dec;11(6):633-9.
4
Occurrence of cytomegalovirus infection and factors causing reactivation of the infection among renal transplant recipients: a single center study.肾移植受者中巨细胞病毒感染的发生情况及感染再激活的相关因素:一项单中心研究
Saudi J Kidney Dis Transpl. 2008 Jan;19(1):41-5.
5
[Complications of infections attributed to cytomegalovirus in a group of 52 kidney transplant patients].[一组52例肾移植患者中巨细胞病毒所致感染的并发症]
Ann Med Interne (Paris). 1987;138(5):369-71.
6
Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.接受抢先治疗的巨细胞病毒感染高危患者的长期肾移植功能及生存率
Rev Invest Clin. 2008 Sep-Oct;60(5):365-74.
7
Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants.巨细胞病毒感染:对320例连续肾移植患者的定量前瞻性研究。
Surgery. 1981 Jun;89(6):660-71.
8
[Clinical course of cytomegalovirus infection in renal transplant recipients].[肾移植受者巨细胞病毒感染的临床病程]
Rev Med Chil. 1999 Jan;127(1):9-17.
9
Severe graft rejection, increased immunosuppression, and active CMV infection in renal transplantation.肾移植中的严重移植物排斥反应、免疫抑制增强及活动性巨细胞病毒感染
J Med Virol. 2006 Mar;78(3):394-9. doi: 10.1002/jmv.20552.
10
IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.通过免疫印迹法检测ppUL80A和ppUL32的IgM抗体:肾移植受者复发性巨细胞病毒感染的早期指标
J Med Virol. 1996 Mar;48(3):289-94. doi: 10.1002/(SICI)1096-9071(199603)48:3<289::AID-JMV13>3.0.CO;2-8.